Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

ClinicalTrials.gov ID: NCT01194375

Public ClinicalTrials.gov record NCT01194375. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 3:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01194375
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dow Pharmaceutical Sciences
Industry
Enrollment
180 participants

Conditions and interventions

Conditions

Interventions

  • Low Strength IDP-107 Drug
  • High Strength IDP-107 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2010
Primary completion
Nov 30, 2011
Completion
Nov 30, 2011
Last update posted
Jul 1, 2012

2010 – 2011

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Dermatology Specialists, Inc. Oceanside California 92056
Horizons Clinical Research Center, LLC Denver Colorado 80220
North Florida Dermatology Associates, PA Jacksonville Florida 32204
FXM Research Corp. Miami Florida 33175
Ameriderm Research Ormond Beach Florida 32174
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256
The Indiana Clinical Trials Center, PC Plainfield Indiana 46168
Pedia Research LLC Owensboro Kentucky 42301
ActivMed Practices and Research, Inc. Haverhill Massachusetts 01830
Hamzavi Dermatology Fort Gratiot Michigan 48059
Minnesota Clinical Study Center Fridley Minnesota 55432
Comprehensive Clinical Research Berlin New Jersey 08009
Oregon Dermatology and Research Center Portland Oregon 97210
DermResearch, Inc. Austin Texas 78759
Dermatology Research Center, Inc. Salt Lake City Utah 84124
South Valley Dermatology West Jordan Utah 84088
Premier Clinical Research Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01194375, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 1, 2012 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01194375 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →